Colorectal cancer
Conditions
Interventions
Thunderbolt moxibustion group A:On the basis of the control group, thunderbolt moxibustion treatment was given, followed by moxibustion bilateral Laogong and Yongquan, with point, press, kneading and
Thunderbolt moxibustion group C:Thunderbolt moxibustion was given on the basis of the control group. The operation method, acupoint selection and course of treatment were the same as those of thunderb
Thunderbolt moxibustion group B:Thunderbolt moxibustion was given on the basis of the control group. Operation method, acupoint selection and course of treatment were the same as thunderbolt moxibusti
Control group:Routine nursing and health education were used. Routine care includes daily life emotional care dietary guidance and other contents. Health education includes keeping warm wearing cotton
Sponsors
Affiliated Hospital of Nanjing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Pathologically confirmed diagnosis of colorectal cancer; (2) 18 to 75 years of age; (3) the first use of XELOX chemotherapy; (4) at least 1 month before the trial did not use calcium channel blockers, tricyclic antidepressants, membrane stabilization drugs; (5) patients voluntarily joined the study and signed informed consent.
Exclusion criteria
Exclusion criteria: (1) suffering from other diseases that can easily cause peripheral neuropathy, such as diabetes, Parkinson 's disease; (2) having serious cardiovascular and cerebrovascular diseases or abnormal liver and kidney function; (3) bone marrow suppression and coagulation dysfunction; (4) suffering from mental or psychological diseases, can not cooperate with the treatment; (5) moxibustion site skin ulceration; (6) excessive heat syndrome or yin deficiency and fire excess and other moxibustion contraindications; (7) thunderbolt moxibustion smoke or drug allergy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| chemotherapy-induced peripheral neuropathy assessment tool, CIPNAT; | — |
Secondary
| Measure | Time frame |
|---|---|
| EORTC QLQ-C30;Numerical Rating Scale, NRS;Berg Balance Scale, BBS;Thermal radiation value of infrared thermal imaging; | — |
Countries
CHINA
Contacts
Public ContactHe Yanyan
Affiliated Hospital of Nanjing University of Chinese Medicine
Outcome results
None listed